Pharma Phorum

DECEMBER 4, 2022

Clinical trials of a wireless brain chip developed by Elon Muck’s Neuralink company will be tested in human volunteers within the next six months – and Musk himself says he intends to have one implanted for a future demo event.

FDA 90

FDA 90

Pharmaceutical Technology

DECEMBER 4, 2022

Starting in January, multiple biosimilars of AbbVie’s blockbuster drug Humira are set to flood the US pharmaceutical market.

Labelling 87

Labelling Communication Hospitals FDA 87

Pharma Phorum

DECEMBER 4, 2022

Contrary to Big Tech, historically the pharmaceutical industry has had a good reputation for being a female-positive industry. However, both industries share a common problem: failure to provide women with C-suite opportunities.

86

86

Pharmacy Times

DECEMBER 4, 2022

Scott Soefje, director of Pharmacy Cancer Care and assistant professor of Pharmacy at Mayo Clinic, discusses PD-1 inhibitors and its use in non–small cell lung cancer.

Mayo Clinic 65

Mayo Clinic 65

Pharma Phorum

DECEMBER 4, 2022

Amgen and Sanofi have said they may make cash-only offers for Horizon Therapeutics, which confirmed it was in talks with potential buyers last week, but Johnson & Johnson has ruled itself out of the running.

79

79

Pharma Phorum

DECEMBER 4, 2022

Amgen is lagging behind rivals like Novo Nordisk and Eli Lilly with its new-generation therapy for obesity, but is sufficiently encouraged by early-stage clinical data to kick off a phase 2 programme for the drug next year.

FDA 75

FDA 75